Hemangiopericytoma — Trials

Hemangiopericytoma — Trials · CancerIndex

Clinical trials

Registered studies

10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–10 of 10 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05259605	Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification	recruiting	—	1,650	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	12	Dec 17, 2025	clinicaltrials
NCT03016091	A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma	terminated	Phase 2	18	Rabin Medical CenterOTHER	1	Feb 18, 2025	clinicaltrials
NCT04648462	Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology	recruiting	—	1,500	Maastricht Radiation OncologyOTHER	1	Nov 26, 2024	clinicaltrials
NCT01117844	Proton Radiation For Meningiomas and Hemangiopericytomas	completed	Phase 1 / Phase 2	53	Abramson Cancer Center at Penn Medicine

Data updated 22 days agoSource updated Dec 17, 2025source: clinicaltrials